Sanuwave Health (SNWV)
NASDAQ:SNWV
Want to see SNWV full AI Analyst Report?
Earnings Data
Report Date
Aug 18, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.03Last Year’s EPS
0.01Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed cautious optimism: underlying demand signs and product adoption are improving (record applicator units, active systems growth, strong consumables usage, a growing large‑account pipeline, maintained full‑year guidance), but near‑term profitability metrics show pressure (gross margin compression, higher operating expenses, negative GAAP EBITDA) driven by reseller mix, one‑time remediation costs and market disruption from CMS actions. Management presents the issues as largely transitory and supported by a strengthening commercial pipeline.Company Guidance
Record Q1 Revenue
Revenue of $9.6M in Q1 2026, up 3% year‑over‑year from $9.3M; highest Q1 revenue in company history (growth at the low end of quarterly guidance of 3%–10%).
Record Applicator Unit Sales and Active Systems Growth
Company sold 97 systems in Q1 and reported a net increase of 90 active systems to 1,382 (from 1,292 at year‑end), driving an all‑time record in applicator unit sales.
Strong Consumables Traction
Consumables utilization increased 22% year‑over‑year and 4% sequentially from Q4 2025, signaling improving usage per system.
Improved Net Loss and Lower Interest Expense
Net loss narrowed to $1.4M in Q1 2026 versus a $6.1M loss in Q1 2025 (improvement of $4.7M), driven largely by the nonrecurrence of a $4.9M noncash derivative loss in the prior year; interest expense was $1.4M lower year‑over‑year following senior debt refinancing.
Maintained Guidance and Growing Pipeline
Company maintained full‑year guidance of $51M–$55M and provided Q2 guidance of 10%–15% YoY growth ($11.1M–$11.6M); management cites increased engagement and evaluations with large national systems and a successful SAWC conference as drivers of second‑half optimism.
Sales Tax Remediation Progress
Entered voluntary disclosure agreements (VDAs) with almost all applicable states to limit look‑back exposure and abate penalties; meaningful progress reported with third‑party tax advisers.
SNWV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SNWV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2026 | $16.04 | $18.94 | +18.08% |
Mar 27, 2026 | $18.85 | $18.61 | -1.27% |
Nov 07, 2025 | $26.41 | $31.08 | +17.68% |
Aug 08, 2025 | $34.32 | $39.76 | +15.85% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sanuwave Health (SNWV) report earnings?
Sanuwave Health (SNWV) is schdueled to report earning on Aug 18, 2026, TBA (Confirmed).
What is Sanuwave Health (SNWV) earnings time?
Sanuwave Health (SNWV) earnings time is at Aug 18, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SNWV EPS forecast?
SNWV EPS forecast for the fiscal quarter 2026 (Q2) is -0.03.